Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan based micro- and nanoparticles in drug delivery. J Control Release 100(1):5–28. https://doi.org/10.1016/j.jconrel.2004.08.010
2. Ahmed SA, El-Mahallawy HS, Karanis P (2019) Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts. Parasitol Res 118(7):2053–2063. https://doi.org/10.1007/s00436-019-06364-0
3. Allam AF, Shehab AY, Mogahed NMFH, Farag HF, Elsayed Y, El-Latif NF (2020) Effect of nitazoxanide and spiramycin metronidazole combination in acute experimental toxoplasmosis. Heliyon 6(4):e03661. https://doi.org/10.1016/j.heliyon.2020.e03661
4. Araujo FG, Prockocimer P, Lin L, Remington SJ (1992) Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. Antimicrob Agents Chemother 36:2454–2457. https://doi.org/10.1128/aac.36.11.2454
5. Asgari Q, Keshavarz H, Shojaee S, Motazedian MH, Mohebali M, Miri R, Mehrabani D, Rezaeian M (2013) In vitro and in vivo potential of RH strain of Toxoplasma gondii [Type I] in tissue cyst forming. Iran J Parasitol 8(3):367–375
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献